| Pancreatic cancer: a review W Park, A Chawla, EM O’Reilly Jama 326 (9), 851-862, 2021 | 1340 | 2021 |
| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ... Nature 618 (7963), 144-150, 2023 | 705 | 2023 |
| Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial BA Wilky, MM Trucco, TK Subhawong, V Florou, W Park, D Kwon, ... The lancet oncology 20 (6), 837-848, 2019 | 348 | 2019 |
| New perspectives of curcumin in cancer prevention W Park, ARMR Amin, ZG Chen, DM Shin Cancer prevention research 6 (5), 387-400, 2013 | 317 | 2013 |
| Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection W Park, J Chen, JF Chou, AM Varghese, KH Yu, W Wong, M Capanu, ... Clinical Cancer Research 26 (13), 3239-3247, 2020 | 201 | 2020 |
| Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer M Reyngold, EM O’Reilly, AM Varghese, M Fiasconaro, M Zinovoy, ... JAMA oncology 7 (5), 735-738, 2021 | 161 | 2021 |
| Cost-effectiveness of osimertinib in the first-line treatment of patients with EGFR-mutated advanced non–small cell lung cancer PN Aguiar, B Haaland, W Park, P San Tan, A Del Giglio, G de Lima Lopes JAMA oncology 4 (8), 1080-1084, 2018 | 127 | 2018 |
| Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3 PN Ganji, W Park, J Wen, H Mahaseth, J Landry, AB Farris, F Willingham, ... Angiogenesis 16, 903-917, 2013 | 123 | 2013 |
| Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer GP Nagaraju, TE Long, W Park, JC Landry, LT Taliaferro‐Smith, AB Farris, ... Molecular carcinogenesis 54 (10), 1147-1158, 2015 | 113 | 2015 |
| Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non‐small cell lung cancer YK Chae, AA Davis, S Agte, A Pan, NI Simon, WT Iams, MR Cruz, ... The oncologist 24 (6), 820-828, 2019 | 112 | 2019 |
| Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors A Dunbar, KL Bolton, SM Devlin, F Sanchez-Vega, J Gao, JV Mones, ... Blood, The Journal of the American Society of Hematology 137 (15), 2103-2113, 2021 | 86 | 2021 |
| Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort AR Naqash, B Ricciuti, DH Owen, V Florou, Y Toi, C Cherry, M Hafiz, ... Cancer Immunology, Immunotherapy 69, 1177-1187, 2020 | 85 | 2020 |
| Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop D Bedognetti, M Ceccarelli, L Galluzzi, R Lu, K Palucka, J Samayoa, ... Journal for immunotherapy of cancer 7, 1-23, 2019 | 84 | 2019 |
| Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma CA McIntyre, SA Lawrence, AL Richards, JF Chou, W Wong, M Capanu, ... Cancer 126 (17), 3939-3949, 2020 | 69 | 2020 |
| Early-onset pancreas cancer: clinical descriptors, genomics, and outcomes AM Varghese, I Singh, R Singh, S Kunte, JF Chou, M Capanu, W Wong, ... JNCI: Journal of the National Cancer Institute 113 (9), 1194-1202, 2021 | 57 | 2021 |
| MITI minimum information guidelines for highly multiplexed tissue images BEA Schapiro D, Yapp C, Sokolov A, Reynolds SM, Chen YA, Sudar D, Xie Y ... Nature Methods, 10.1038/s41592-022-01415-4, 2022 | 56* | 2022 |
| Developing a predictive model for clinical outcomes of advanced non-small cell lung cancer patients treated with nivolumab W Park, D Kwon, D Saravia, A Desai, F Vargas, M El Dinali, J Warsch, ... Clinical lung cancer 19 (3), 280-288. e4, 2018 | 55 | 2018 |
| The concept of biosimilars: from characterization to evolution—a narrative review F Farhat, A Torres, W Park, G de Lima Lopes, R Mudad, C Ikpeazu, ... The oncologist 23 (3), 346-352, 2018 | 49 | 2018 |
| Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics L Mezquita, I Preeshagul, E Auclin, D Saravia, L Hendriks, H Rizvi, ... European Journal of Cancer 151, 211-220, 2021 | 48 | 2021 |
| A dual‐targeting antibody against EGFR‐VEGF for lung and head and neck cancer treatment H Zhang, S Yun, TD Batuwangala, M Steward, SD Holmes, L Pan, ... International journal of cancer 131 (4), 956-969, 2012 | 47 | 2012 |
Eileen M. O'ReillyMemorial Sloan Kettering Cancer CenterEmail được xác minh tại mskcc.org